Image Source: Indian Retailer
India's leading pharmaceutical major, Sun Pharmaceutical Industries Ltd., released its key leadership announcements. Dilip Shanghvi will continue to be the Executive Chairman of the Board to ensure continuity and give strategic direction to the company. Kirti Ganorkar has joined as the Managing Director, representing a significant leadership change.
Ganorkar, who played a key role in the growth of Sun Pharma, will now be responsible for Sun Pharma's business and strategic efforts. His appointment is expected to further strengthen Sun Pharma's hold in the global pharmaceutical sector.
These leadership changes take place when Sun Pharma is planning gigantic investments in specialty drugs, like a $100 million investment in the commercialization of innovative therapies2. It has also made a recent acquisition of Checkpoint Therapeutics, adding to its oncology division.
With these actions, Sun Pharma goes on to emphasize its leadership and innovation focus in the pharma industry.
Sources: Rediff Money, The Hindu Business Line, Medical Dialogues
India's leading pharmaceutical major, Sun Pharmaceutical Industries Ltd., released its key leadership announcements. Dilip Shanghvi will continue to be the Executive Chairman of the Board to ensure continuity and give strategic direction to the company. Kirti Ganorkar has joined as the Managing Director, representing a significant leadership change.
Ganorkar, who played a key role in the growth of Sun Pharma, will now be responsible for Sun Pharma's business and strategic efforts. His appointment is expected to further strengthen Sun Pharma's hold in the global pharmaceutical sector.
These leadership changes take place when Sun Pharma is planning gigantic investments in specialty drugs, like a $100 million investment in the commercialization of innovative therapies2. It has also made a recent acquisition of Checkpoint Therapeutics, adding to its oncology division.
With these actions, Sun Pharma goes on to emphasize its leadership and innovation focus in the pharma industry.
Sources: Rediff Money, The Hindu Business Line, Medical Dialogues
Stay Ahead – Explore Now!
ACME Solar Lands Rs 3,892 Crore Funding From SBI for 400 MW Renewable Energy Project
Advertisement
Advertisement